Plain English Summary
Background and study aims
Coronary heart disease (CHD), also known as ischemic heart disease, is one of the leading causes of death worldwide. CHD develops because of the build-up of fatty deposits (plaque) on the walls of the coronary arteries (the arteries that supply the heart with oxygen-rich blood). When arteries are blocked or narrowed, the heart does not receive enough blood to function properly, which can cause pain and tightness in the chest (angina), or a heart attack. Depression is very common in patients with CHD, and it has been found that these patients are more likely to have a heart attack or die. There are very effective treatments for CHD and depression separately, however there is not currently any good ways of treating both of these conditions simultaneously. The aim of this study is to find out whether a personalised care programme could be an effective treatment strategy for people suffering from CHD and depression.
Who can participate?
CHD patients over 16 years old with chest pain who are suffering from depression and the GP practices that care for them.
What does the study involve?
Participants are randomly allocated to one of two groups. Those in the first group continue to receive their usual treatment from their GP and/or practice nurse. Those in the second group continue to receive usual care but also take part in the personalised care plan for 6 months, which is given by two case managers (a community psychiatric nurse and a health psychologist who is also a qualified nurse). At the start of the study, the case managers meet with the patient in order to draw-up a 6-month personalised care plan by talking about the current problems the patient is experiencing, which is passed on to the patient’s GP. The patient then works to achieve the goals set in their care plan and are followed up weekly by telephone to see how they are getting on. At the start of the study and then again after 6 months and 1 year, participants in both groups complete a number of questionnaires in order to assess any changes to their CHD and their mental wellbeing.
What are the possible benefits and risks of participating?
Not provided at time of registration
Where is the study run from?
General Practices based in South London (UK)
When is the study starting and how long is it expected to run for?
March 2010 to March 2012
Who is funding the study?
National Institute for Health Research (UK)
Who is the main contact?
Professor Andre Tylee
Prof Andre Tylee
Institute of Psychiatry
PO Box 28
+44 (0)20 7848 0150
UPBEAT-UK: A pilot randomised controlled trial of case management for depressed primary care patients with symptomatic coronary heart disease
The principal research objective is to pilot case management as an intervention in primary care patients with depression and coronary heart disease (CHD) in order to inform a definitive randomised controlled trial (RCT).
South East London Research Ethics Committee, ref:10/H0808/51
Pilot randomised controlled trial
Primary study design
Secondary study design
Randomised controlled trial
Patient information sheet
Coronary heart disease/comorbid depression
Experimental intervention (usual care plus case management):
The intervention will be case management delivered by two clinically qualified researchers (a community psychiatric nurse and a health psychologist who is also a qualified nurse).
The case managers will arrange to meet with the participant for an initial assessment. The meeting may be at the patient's surgery, home or place of work according to the participant's preference. At the assessment, the case managers will draw-up with the participants a personalised care plan (PCP). This will take a holistic approach to the participant's current problems. A copy of the PCP will be kept by the participant, a copy by the case manager and a copy sent to the participant's GP. The case manager will help the participant choose up to two more complex problems, for example a need to increase exercise or to reduce social isolation, to work on using a goal setting technique to enhance their self-efficacy. Where appropriate, the case managers will provide written information about depression or direct the patient to other resources. Written materials and other resources will be pre-published and freely available, for instance mental health charity web pages or leaflets, that have been identified by the case managers as of good quality. The initial assessment is likely to last up to an hour. The case manager will liaise with other health professionals involved in the participant's care as appropriate.
Participants will be followed up by the case manager by telephone for 6 months. Initially, contact is likely to be at least weekly, but later may be two-weekly. During the follow-up, the participant's PCP will be reviewed and new goals set in collaboration with the participant as appropriate.
Usual care by the participant's GP and other relevant health professionals.
The treatment will be provided for 6 months, follow up will be for 1 year.
Primary outcome measure
Since this is a pilot study, an aim is to identify appropriate primary and secondary outcome measures. The following measures will be tested:
1. Depression (HADS, 9-item Patient Health Questionnaire [PHQ-9])
2. Coronary Heart Disease (Modified Rose Angina Questionnaire, Specific Activity Schedule)
3. Quality of Life (Euroqol 5D, 12-item Medical Outcomes Survey Short Form [SF-12])
4. Adherence to medication (Adapted version of Morisky adherence questionnaire)
5. Life events (List of Threatening Events Questionnaire)
6. Social problems (Social Problems Questionnaire)
7. Health Service Utilisation (Client Service Receipt Inventory (CSRI))
8. Illness Perceptions (Brief Illness Perceptions Questionnaire)
9. Participants' problem priorities (Psychlops)
Assessments will be at 1, 6 and 12 months for all outcomes.
Secondary outcome measures
No secondary outcome measures
Overall trial start date
Overall trial end date
Reason abandoned (if study stopped)
Participant inclusion criteria
1. Keep a register of patients with CHD for the Quality and Outcomes Framework (QOF)
2. Willing to liaise over patients in the case management arm when necessary
1. Symptomatic CHD as scored on the modified Rose Angina Questionnaire
2. Score greater than 9 on the Hospital Anxiety and Depression Scale (HADS)
3. Aged 16 years or over, either sex
Target number of participants
60 (30 randomised to each arm)
Participant exclusion criteria
1. Temporary registrations
2. Actively suicidal or experiencing psychotic depression as evidenced by delusions and/or hallucinations
3. Under the care of secondary care mental health teams
4. Cannot speak English
5. Currently in hospital for treatment of their CHD
Recruitment start date
Recruitment end date
Countries of recruitment
Trial participating centre
King's College London
National Institute for Health Research
Funding Body Type
Funding Body Subtype
Results and Publications
Publication and dissemination plan
Planned publication in a peer reviewed journal.
Intention to publish date
Participant level data
Not provided at time of registration
Basic results (scientific)
Tylee A, Haddad M, Barley E, Ashworth M, Brown J, Chambers J, Farmer A, Fortune Z, Lawton R, Leese M, Mann A, McCrone P, Murray J, Pariante C, Phillips R, Rose D, Rowlands G, Sabes-Figuera R, Smith A, Walters P, A pilot randomised controlled trial of personalised care for depressed patients with symptomatic coronary heart disease in South London general practices: the UPBEAT-UK RCT protocol and recruitment., BMC Psychiatry, 2012, 12, 58, doi: 10.1186/1471-244X-12-58.
Barley EA, Walters P, Haddad M, Phillips R, Achilla E, McCrone P, Van Marwijk H, Mann A, Tylee A, The UPBEAT nurse-delivered personalized care intervention for people with coronary heart disease who report current chest pain and depression: a randomised controlled pilot study, PLoS One, 2014, 9, 6, e98704, doi: 10.1371/journal.pone.0098704.